Laura Strauss

Q: What is Laura Strauss email address?

Email Laura Strauss at laurastrauss@bidmc.org. This email is the most updated Laura Strauss email found in 2026.

Q: How to contact Laura Strauss?

To contact Laura Strauss send an email to laurastrauss@bidmc.org. (updated on October 29, 2024)

Sr. Principal Scientist, Pre-clinical Immuno-Oncology Lead at GenVivo, Inc. | Boston, Massachusetts, United States

About Laura Strauss

Laura Strauss is a highly accomplished Senior Principal Scientist at GenVivo, Inc., where she serves as the Pre-clinical Immuno-Oncology Lead. With a robust background in immunology and a keen focus on immuno-oncology, Laura is at the forefront of developing innovative off-the-shelf immunotherapies utilizing GenVivo’s proprietary gene delivery technology. Her expertise lies in harnessing the immune system to mount a targeted attack against solid tumors, a critical area of research that holds the promise of transforming cancer treatment.

In her current role, Laura is leading key projects that explore the intricacies of immunometabolism and its impact on tumor microenvironments. She employs her extensive knowledge in cellular and molecular biology to design and execute both in vitro and in vivo studies, ensuring that the therapies developed are not only effective but also safe for clinical application. Her proficiency in advanced techniques such as flow cytometry and single-cell sorting allows her to analyze complex immune responses at an unprecedented resolution, providing invaluable insights into the mechanisms of action of the therapies under development.

Laura's commitment to scientific excellence is reflected in her strong research output, which has been instrumental in advancing GenVivo’s mission to deliver cutting-edge immunotherapies. Her multilingual capabilities in German, Spanish, and French further enhance her ability to collaborate with international research teams, fostering a global perspective in her work. As a creative and driven scientist, Laura continues to push the boundaries of what is possible in the field of immuno-oncology, making significant strides towards improving patient outcomes in the fight against cancer.

Laura Strauss Work